Company Description
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States.
It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen.
Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Country | United States |
Founded | 1997 |
IPO Date | May 23, 2014 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 19 |
CEO | Alfred F. Altomari |
Contact Details
Address: 500 College Road East, Suite 310 Princeton, New Jersey 08540-6635 United States | |
Phone | 609-683-1880 |
Website | agiletherapeutics.com |
Stock Details
Ticker Symbol | AGRX |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001261249 |
CUSIP Number | 00847L100 |
ISIN Number | US00847L3087 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Alfred F. Altomari | Chairman, President and Chief Executive Officer |
Geoffrey P. Gilmore | Senior Vice President and Chief Administrative Officer |
Dr. Paul Korner M.B.A., M.D. | Senior Vice President and Chief Medical Officer |
Scott M. Coiante | Chief Financial Officer, Senior Vice President and Treasurer |
Matthew Riley | Head of Investor Relations and Corporate Communications |
Robert G. Conway M.E. | Senior Vice President and Chief Corporate Planning and Supply Chain Officer |
Amy Welsh | Senior Vice President and Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 2, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Jun 27, 2024 | RW | Filing |
Jun 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Jun 26, 2024 | 8-K | Current Report |
Jun 14, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Jun 3, 2024 | 25-NSE | Filing |
May 21, 2024 | 8-K | Current Report |
May 15, 2024 | 10-Q | Quarterly Report |
May 15, 2024 | 8-K | Current Report |
Apr 29, 2024 | 10-K/A | [Amend] Annual report |